Dr Oliver Bartley

BSc PhD

2025

• Hakami, A. et al. 2025. Graft ischemia post cell transplantation to the brain: Glucose deprivation as the primary driver of rapid cell death. Neurotherapeutics 22(2), article number: e00518. (10.1016/j.neurot.2024.e00518)

2024

• Hennegan, J. et al. 2024. Inhibition of 7α,26-dihydroxycholesterol biosynthesis promotes midbrain dopaminergic neuron development. iScience 27(1), article number: 108670. (10.1016/j.isci.2023.108670)

2022

• Jareno, P. G., Bartley, O., Precious, S., Rosser, A. and Lelos, M. 2022. Challenges in progressing cell therapies to the clinic for Huntington's disease: A review of the progress made with pluripotent stem cell derived medium spiny neurons. In: Lane, E. L., Drew, C. and Lelos, M. J. eds. International Review of Neurobiology: Current Challenges in Cell Therapy for Neurodegenerative Diseases., Vol. 166. Elsevier, pp. 1-48., (10.1016/bs.irn.2022.09.003)

2021

• Bartley, O. J. M., Lelos, M. J., Gray, W. P. and Rosser, A. E. 2021. Do foetal transplant studies continue to be justified in Huntington's disease?. Neuronal Signaling 5, article number: acerbic. (10.1042/NS20210019)
• Rizzo, S. A., Bartley, O., Rosser, A. E. and Newland, B. 2021. Oxygen-glucose deprivation in neurons: implications for cell transplantation therapies. Progress in Neurobiology 205, article number: 102126. (10.1016/j.pneurobio.2021.102126)
• Choompoo, N. et al. 2021. Induced pluripotent stem cells derived from the developing striatum as a potential donor source for cell replacement therapy for Huntington disease. Cytotherapy 23(2), pp. 111-118. (10.1016/j.jcyt.2020.06.001)

2019

• Bartley, O. J. M. 2019. Does epigenetic memory influence the differentiation of MSNs from fetal ganglionic eminence derived iPS cells?. PhD Thesis, Cardiff University.